Drug dissolution: Significance of physicochemical properties and physiological conditions

Drug Discovery Today

Volumn 18, Issue 23-24, 2013, Pages 1173-1184

  Jambhekar, Sunil S ^a   Breen, Philip J ^b  

^a LAKE ERIE COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLODEXTRIN; SURFACTANT; DRUG;

COMPLEX FORMATION; DRUG BIOAVAILABILITY; DRUG SOLUBILITY; PARTICLE SIZE; PHYSICAL CHEMISTRY; PHYSIOLOGY; PKA; REVIEW; SMALL INTESTINE; SOLUBILIZATION; STOMACH JUICE; STOMACH PH; SURFACE PROPERTY; BIOAVAILABILITY; CHEMISTRY; DRUG RELEASE; GASTROINTESTINAL TRACT; HUMAN; INTESTINE ABSORPTION; MEDICINAL CHEMISTRY; METABOLISM; ORAL DRUG ADMINISTRATION; PERMEABILITY; SOLUBILITY;

ADMINISTRATION, ORAL; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; DRUG LIBERATION; GASTROINTESTINAL TRACT; HUMANS; INTESTINAL ABSORPTION; PERMEABILITY; PHARMACEUTICAL PREPARATIONS; SOLUBILITY;

EID: 84889079603     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2013.08.013     Document Type: Review

References (73)

1. D. Sun In-vitro testing of drug absorption for drug 'developability' assessment: forming an interface between in vitro preclinical data and clinical outcome Curr. Opin. Drug Discov. Dev. 7 2004 75 85
2. K.C. Kwan Oral bioavailability and first pass effects Drug Metab. Dispos. 25 1997 1329 1336
3. G.L. Amidon Estimating human oral fraction dose absorbed: a correlation using rat intestinal membrane permeability for passive and carrier-mediated compounds Pharm. Res. 5 1988 651 654
4. G.W. Caldwell Compound optimization in early and late phase drug discovery: acceptable pharmacokinetics properties utilizing combined physicochemical, in vitro and in vivo screens Curr. Opin. Drug Discov. Dev. 3 2000 30 41
5. S. Venkatesh, and R.A. Lipper Role of the development scientist in compound lead selection and optimization J. Pharm. Sci. 89 2000 145 154
6. M.B. Brennan Drug discovery: filtering out failures early in the game Chem Eng. News 2000 63 June 5
7. A. Noyes, and W.J. Whitney The rate of solution of solid substances in their own solution J. Am. Chem. Soc. 19 1897 930 934
8. A. Noyes, and W.J. Whitney Ueber die auslosungsgesch wingdigkeit von festen stossen in ihern eigenen losungen Z. Physik. Chem. 23 1897 689 692
9. E. Bruner, and W. Nernst Realktionsgeschwindigkeit nin heterogenen system Z. Physik. Chem. 47 1904 56 102
10. A. Hixson, and J. Crowell Dependence of reaction velocity upon surface and agitation I: theoretical consideration Ind. Eng. Chem. 23 1931 923 931
11. A. Hixson, and J. Crowell Dependence of reaction velocity upon surface and agitation II: Theoretical consideration Ind. Eng. Chem. 23 1931 1002 1009
12. P.J. Niebergall, and J.E. Goyan Dissolution rate studies I J. Pharm Sci. 52 1963 29 33
13. P.J. Niebergall Dissolution rate studies II. Dissolution of particles under conditions of rapid agitation J. Pharm. Sci. 52 1963 236 241
14. J.E. Goyan Dissolution rate studies III. Penetration model for describing dissolution of multiparticulate system J. Pharm. Sci. 54 1965 645 647
15. W.I. Higuchi, and E.N. Hiestand Dissolution rates of finely divided drug powders I. Effect of distribution of particle sizes in a diffusion controlled process J. Pharm. Sci. 52 1963 67 71
16. W.I. Higuchi Dissolution rates of finely divided drug powders II. Micronized methylprednisolone J. Pharm. Sci. 52 1963 162 164
17. D. Horter, and J.B. Dressman Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract Adv. Drug Deliv. Res. 46 2002 75 87
18. R.J. Braun, and E.L. Parrott Influence of viscosity and solubilization on dissolution rate J. Pharm. Sci. 61 1972 175 178
19. D.E. Wurster, and G.P. Polli Investigation of drug release from solids V: simultaneous influence of adsorption and viscosity on the dissolution rate J. Pharm. Sci. 53 1964 311 314
20. L.J. Naylor Dissolution of steroids in bile salt solutions is modified by the presence of lecithin Eur. J. Pharm. Biopharm. 41 1995 346 353
21. C. Reppas Effect of hydroxypropylmethylcellulose on gastrointestinal transit and luminal viscosity in dogs Gastroenterology 100 1991 1217 1223
22. S. Solvang, and P. Finholt Effect of tablet processing and formulation factors on dissolution rate of the active ingredient in human gastric juice J. Pharm. Sci. 59 1970 49 52
23. P. Finholt, and S. Solvang Dissolution kinetics of drugs in human gastric juice - the role of surface tension J. Pharm. Sci. 57 1968 1322 1326
24. V. Bakatselou Solubilization and wetting effects of bile salts on the dissolution of steroids Pharm. Res. 8 1991 1461 1469
25. L.J. Naylor Comparison of the mechanism of dissolution of hydrocortisone in simple and mixed micelle systems Pharm. Res. 10 1993 865 870
26. A. Dresse Human pharmacokinetics of two crystalline and galenic forms of diflunisal, a new analgesic Pharm. Acta Helv. 53 1978 177 181
27. A.J. Aguiar Effect of polymorphism on the absorption of chloramphenicol from chloramphenicol palmitate J. Pharm. Sci. 56 1967 847 853
28. B. Katchen, and S. Symchowicz Correlation of dissolution rate and griseofulvin absorption in man J. Pharm. Sci. 56 1967 1108 1110
29. Solubilization D. Attwood, and A.T. Florence Surfactant Systems 1983 Chapman and Hall London 229
30. J.H. Collett, and L. Koo Interaction of substituted benzoic acids with polysorbate 20 micelles J. Pharm. Sci. 64 1975 1253 1255
31. B.W. Barry, and D.I.D. El Eini Solubilization of hydrocortisone, dexamethasone, testosterone and progesterone by long-chain polyoxyethylene surfactants J. Pharm. Pharmacol. 28 1976 210 218
32. Pharmaceutical aspects of solubilization D. Attwood, and A.T. Florence Surfactant Systems 1983 Chapman and Hall London 298 299
33. H. Tomida Solubilization of steroid hormones by polyoxyethylene lauryl ether Chem. Pharm. Bull. 26 1978 2832 2837
34. T.R. Bates Solubilizing properties of bile salt concentration on solubilization of glutethimide, griseofulvin and hexestrol J. Pharm. Sci. 55 1966 191 199
35. M.A. Kassem Study on the influence of sodium taurocholate (STC) and sodium glycocholate (SGC) on the mass transfer of certain drugs: digoxin Int. J. Pharm. 12 1982 1 9
36. 4 antagonist in micellar solutions J. Pharm. Sci. 81 1992 483 485
37. P.E. Luner The effects of bile salts and lipids on the physiochemical behavior of gemfibrozil Pharm. Res. 11 1994 1755 1760
38. W. Shankland The equilibrium and structure of lecithin-cholate mixed micelles Chem. Phys. Lipids 4 1970 109 130
39. M. Rosoff, and A.T.M. Serajuddin Solubilization of diazepam in bile salts and in sodium cholate-lecithin-water phases Int. J. Pharm. 6 1980 137 146
40. S.D. Mithani Estimation of the increase in solubility of drugs as a function of bile salt concentration Pharm. Res. 13 1996 163 167
41. S. Miyazaki Micellar interaction of indomethacin and phenylbutazone with bile salts Int. J. Pharm. 8 1981 303 310
42. V.J. Stella, and J.D. Pipkin Phenylbutazone ionization kinetics J. Pharm. Sci. 65 1976 1161 1165
43. J.R. Malagelada Measurement of gastric functions during digestion of ordinary solid meals in man Gastroenterology 70 1976 203 210
44. R.A. Blum Increased gastric pH and the bioavailability of fluconazole and ketoconazole Ann. Intern. Med. 114 1991 755 757
45. T. Zimmerman Influence of concomitant food intake on the oral absorption of two triazole antifungal agents, itraconazole and fluconazole Eur. J. Clin. Pharmacol. 46 1994 147 150
46. W. Martindale Dissociation constants The Extra Pharmacopeia 1982 The Pharmaceutical Press London XXIV XXVII
47. G. Lake-Bakaar Gastropathy and ketoconazole malabsorption in the acquired immune-deficiency syndrome (AIDS) Ann. Intern. Med. 109 1988 471 473
48. K.W. Brammer, and M.H. Tarbit A review of the pharmacokinetics of fluconazole (UK-49 858) in laboratory animals and man R.A. Fromtling, Recent Trends in the Discovery, Development and Evaluation of Antifungal Agents 1987 J.R. Prous Science Publishers Barcelona 141 149
49. H.P. Deppeler Hydrchlorothiazide K. Florey, Analytical Profiles of Drug Substances vol. 10 1981 Academic Press New York 405 437
50. S.S. Ozturk Dissolution of ionizable drugs in buffered and un-buffered solutions Pharm. Res. 5 1988 272 282
51. A.A. Rasool Solubility enhancement of some water-insoluble drugs in the presence of nicotinamide and related compounds J. Pharm. Sci. 80 1991 387 393
52. J. Truelove Solubility enhancement of some developmental anti-cancer nucleoside analogs by complexation with nicotinamide Int. J. Pharm. 19 1984 17 25
53. T. Tokumura Enhancement of bioavailability of cinnarizine from its β-cyclodextrin complex on oral administration with d,l-phenylalanine as competing agent J. Pharm. Sci. 75 1986 391 394
54. B.G. Woodcock Supermolecular inclusion of piroxicam with β-cyclodextrin: pharmacokinetic properties in man Eur. J. Rheumatol. Inflamm. 12 1993 12 28
55. T. Miyayi Improvement of oral bioavailability of fenbufen by cyclodextrin complexations Acta Pharm. Nord. 4 1992 17 22
56. J.B. Dressman Delivery system technology C. Hansch, Comprehensive Medicinal Chemistry Biopharmaceutics vol. 5 1990 Pergamon Press Oxford 632
57. R. Casella Solid-state β-cyclodextrin complexes containing indomethacin, ammonia, and water I. Formation studies Int. J. Pharm. 165 1998 1 14
58. R. Casella Solid-state β-cyclodextrin complexes containing indomethacin, ammonia, water II. Solubility studies Int. J. Pharm. 165 1998 15 22
59. S.S. Jambhekar The physicochemical characteristics and bioavailability of indomethacin from β-cyclodextrin, hydroxypropyl β-cyclodextrin, and hydroxyethyl β-cyclodextrin complexes Int. J. Pharm. 270 2004 149 166
60. M.E. Brewster Development of aqueous parenteral formulations for carbamazepine through the use of modified cyclodextrins J. Pharm. Sci. 80 1991 380 383
61. A.Y. Tinwalla Solubilization of thiazolobenzimidazole using a combination of pH adjustment and complexation with 2-hydroxpropyl-β-cyclodextrin Pharm. Res. 10 1993 1136 1143
62. T. Jarvinen β-Cyclodextrin derivatives, SBE-β-CD and HP-β-CD, increase the oral bioavailability of cinnarizine in beagle dogs J. Pharm. Sci. 84 1995 295 299
63. Y. Okada Solubilization of lipid-soluble vitamins by complexation with glucosyl-β-cyclodextrin Chem. Pharm. Bull. 38 1990 2047 2049
64. F. Acarturk Comparative study on inclusion complexation of maltosyl-β- cyclodextrin, heptakis (2,6-di-O-methyl-β-cyclodextrin) and β-cyclodextrin with fucosterol in aqueous and solid state J. Pharm. Pharmacol. 45 1993 1028 1032
65. Y. Okada Some properties and the inclusion behavior of branched cyclodextrins Chem. Pharm. Bull. 36 1988 2176 2185
66. P.E. Macheras Drug binding and solubility in milk Pharm. Res. 7 1990 537 541
67. P.E. Macheras, and C.I. Reppas Studies on drug-milk freeze dried formulations I: bioavailability of sulfamethizole and dicumarol formulations J. Pharm. Sci. 75 1986 692 696
68. P.G. Welling Influence of food and diet on gastrointestinal drug absorption: a review J. Pharmacokinet. Biopharm. 5 1977 291 334
69. T.L. Russell Upper gastrointestinal pH in 79 healthy, elderly, North American men and women Pharm. Res. 10 1993 187 196
70. D.F. Evans Measurement of gastrointestinal pH profiles in normal ambulant human subjects Gut 29 1988 1035 1041
71. J.B. Dressman Upper gastrointestinal pH in young, healthy men and women Pharm. Res. 7 1991 756 761
72. L. Ovesen Intraluminal pH in the stomach, duodenum and proximal jejunum in normal subjects and patients with exocrine pancreatic insufficiency Gastroenterology 90 1986 958
73. B. Borgstrom Studies of intestinal digestion and absorption in the human J. Clin. Invest. 36 1957 1521 1536